Litigation is supposed to be a deterrent to dealmaking. For Kimberly-Clark Corp., it’s a spur. The diaper maker on Monday agreed to buy Tylenol producer Kenvue Inc. for $40 billion. This mammoth transaction is a gamble — but one with decent odds.
www.bloomberg.com
#Billion #Tylenol #Deal #Cheap #Risky
That $40 Billion Tylenol Deal Is Both Cheap and Risky
